Switch to:

CRISPR Therapeutics AG Days Sales Outstanding

: 68.44 (As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

CRISPR Therapeutics AG's Accounts Receivable for the three months ended in Jun. 2020 was $0.0 Mil. CRISPR Therapeutics AG's Revenue for the three months ended in Jun. 2020 was $0.0 Mil. Hence, CRISPR Therapeutics AG's days sales outstanding for the three months ended in Jun. 2020 was 68.44.

NAS:CRSP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.04   Med: 23.38   Max: 500.95
Current: 0.04

0.04
500.95

During the past 6 years, CRISPR Therapeutics AG's highest Days Sales Outstanding was 500.95. The lowest was 0.04. And the median was 23.38.

NAS:CRSP's Days Sales Outstanding is ranked higher than
100% of the 725 Companies
in the Biotechnology industry.

( Industry Median: 71.05 vs. NAS:CRSP: 0.04 )

CRISPR Therapeutics AG's days sales outstanding declined from Jun. 2019 (92.11) to Jun. 2020 (68.44).

Warning Sign:

If a company sales outstanding increases, it means it has difficulty collecting payment from its customers.


CRISPR Therapeutics AG Days Sales Outstanding Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Days Sales Outstanding Premium Member Only 500.95 223.14 23.38 10.28 0.12

CRISPR Therapeutics AG Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.11 0.02 0.12 14,598.26 68.44

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


CRISPR Therapeutics AG Days Sales Outstanding Distribution

* The bar in red indicates where CRISPR Therapeutics AG's Days Sales Outstanding falls into.



CRISPR Therapeutics AG Days Sales Outstanding Calculation

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CRISPR Therapeutics AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=0.099/289.59*365
=0.12

CRISPR Therapeutics AG's Days Sales Outstanding for the quarter that ended in Jun. 2020 is calculated as:

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=0.033/0.044*365 / 4
=68.44

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


CRISPR Therapeutics AG  (NAS:CRSP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


CRISPR Therapeutics AG Days Sales Outstanding Related Terms


CRISPR Therapeutics AG Days Sales Outstanding Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)